Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1982-04-13
1984-05-29
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Lymphokine
A61K 3178
Patent
active
044514530
ABSTRACT:
Contact dermatitis caused by exposure of the skin to the allergen present in plants of the genus Rhus, is treated and controlled by topical application of an effective amount of an allergen-imbibing, allergen-retaining polymer or a pharmaceutically-acceptable composition containing such polymer.
REFERENCES:
patent: 3322695 (1967-05-01), Alfrey et al.
patent: 3520806 (1970-07-01), Haigh
patent: 3615972 (1971-10-01), Morehouse et al.
patent: 3750688 (1973-08-01), Hall et al.
patent: 3849576 (1974-11-01), Kalopissis
patent: 3953406 (1976-04-01), Marsh
patent: 3976781 (1976-08-01), Kalopissis
patent: 4039489 (1977-08-01), Fletcher
patent: 4071670 (1978-01-01), Vanzo et al.
patent: 4112067 (1978-09-01), Tomalia et al.
patent: 4186191 (1980-01-01), Chamberlin et al.
Haigh Daniel H.
Lay George E.
Schenkman Leonard
The Dow Chemical Company
LandOfFree
Method for treating contact dermatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating contact dermatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating contact dermatitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1396901